List of insiders holdings for REGENERON PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | 2024-02-20 16:03:46 | 801,608 465,370 | 1,266,978 | Form 4 |
SCHLEIFER LEONARD S Bd. Co-Chair, President & CEO | 2023-12-13 16:05:34 | 374,429 320,901 | 695,330 | Form 4 |
VAGELOS P ROY Director | 2023-04-05 16:02:23 | 312,578 154,526 | 467,104 | Form 4 |
SANOFI-AVENTIS Sanofi-Aventis Amerique du Nord S.N.C. 10% Owner | 2020-06-17 17:10:15 | 279,766 0 | 279,766 | Form 13D |
Sanofi 10% Owner | 2020-06-17 17:10:15 | 279,766 0 | 279,766 | Form 13D |
GOLDBERG MURRAY A SVP Administration & Asst Secr | 2014-12-18 16:25:06 | 142,515 6400 | 148,915 | Form 4 |
RUPP RANDALL SVP, Manufuring Operations | 2007-04-17 14:25:18 | 142,137 0 | 142,137 | Form 4 |
MURPHY ANDREW J EVP Research | 2024-03-15 16:01:02 | 68,306 4310 | 72,616 | Form 4 |
ROBERTS WILLIAM VP Reg Dev & Med Safety | 2014-02-06 16:41:18 | 16,644 55,634 | 72,278 | Form 5 |
GULER HANS PETER VP Clinical Programs | 2004-10-12 12:02:08 | 67,152 0 | 67,152 | Form 4 |
STAHL NEIL EVP Research and Development | 2024-02-28 16:04:05 | 50,999 10,439 | 61,438 | Form 4 |
LAROSA JOSEPH J EVP General Counsel and Secret | 2024-02-28 16:04:48 | 36,543 3722 | 40,265 | Form 4 |
Landry Robert E EVP Finance CFO | 2024-02-06 16:08:17 | 35,480 270 | 35,750 | Form 4 |
Powchik Peter SVP Clinical Development & Reg | 2016-12-19 16:15:06 | 30,714 4133 | 34,847 | Form 4 |
Van Plew Daniel P EVP & General Mgr, Industrial | 2024-02-16 16:15:32 | 20,378 13,460 | 33,838 | Form 4 |
SING GEORGE L Director | 2024-02-28 16:04:19 | 31,687 2150 | 33,837 | Form 4 |
Terifay Robert J EVP Commercial | 2017-12-13 16:52:29 | 32,300 0 | 32,300 | Form 4 |
Fenimore Christopher R. SVP Finance & CFO | 2024-02-12 16:02:02 | 14,372 10,059 | 24,431 | Form 4 |
Dworkin Peter VP Investor Relations & Commun | 2009-12-22 11:21:13 | 23,500 0 | 23,500 | Form 4 |
SHOOTER ERIC M Director | 2014-02-13 19:38:09 | 15,000 5085 | 20,085 | Form 4 |
KOLINSKI STUART SVP General Counsel and Secret | 2010-06-07 16:14:10 | 16,329 3710 | 20,039 | Form 4 |
Aberman Michael S SVP Strategy Investor Relation | 2017-06-23 16:10:08 | 7693 12,253 | 19,946 | Form 4 |
RYAN ARTHUR F Director | 2024-03-05 16:01:49 | 18,282 0 | 18,282 | Form 4 |
Pitofsky Jason Vice President, Controller | 2024-02-08 16:01:21 | 15,816 0 | 15,816 | Form 3 |
INGRAM ROBERT ALEXANDER Director | 2015-05-27 16:02:35 | 14,833 0 | 14,833 | Form 4 |
BROWN MICHAEL S Director | 2024-01-04 16:06:09 | 2989 11,162 | 14,151 | Form 4 |
McCourt Marion EVP Commercial | 2024-03-05 16:01:35 | 13,431 158 | 13,589 | Form 4 |
McCorkle Douglas S VP Controller and Asst Treasur | 2015-12-29 19:44:10 | 6866 4129 | 10,995 | Form 4 |
GILMAN ALFRED G Director | 2015-08-07 18:15:04 | 8912 0 | 8912 | Form 4 |
BAKER CHARLES A Director | 2018-01-03 16:14:21 | 7439 0 | 7439 | Form 4 |
GOLDSTEIN JOSEPH L Director | 2024-01-25 16:18:36 | 6382 0 | 6382 | Form 4 |
Tessier-Lavigne Marc Director | 2023-01-05 16:16:35 | 4363 0 | 4363 | Form 4 |
POON CHRISTINE A Director | 2024-01-04 16:10:07 | 3779 0 | 3779 | Form 4 |
COLES N ANTHONY Director | 2024-01-04 16:11:27 | 3000 0 | 3000 | Form 4 |
Zoghbi Huda Y Director | 2024-01-04 16:11:18 | 2989 0 | 2989 | Form 4 |
Thompson Craig B. Director | 2024-01-04 16:15:45 | 2061 0 | 2061 | Form 4 |
Bassler Bonnie L Director | 2024-02-26 16:07:53 | 1382 0 | 1382 | Form 4 |
Schenkein David P Director | 2024-01-04 16:17:15 | 790 0 | 790 | Form 4 |
Guarini Kathryn Director | 2024-01-04 16:16:40 | 790 0 | 790 | Form 4 |
NOVARTIS PHARMA AG 10% Owner | 2005-11-10 14:56:08 | 0 0 | 0 | Form 13G |